Idenix Pharmaceuticals (IDIX)

[go seek]

1Q07 Hepsera sales were $71.3M ($285M annualized), +35% year-over-year

wow! 35% year over year even w/ Baraclude in the mix...
if anything, i thot Hepsera sales would fall off some.

aren't you surprised by the +35% year-over-year, +8% quarter-over-quarter?

Haven't researched recent sales figures for Baraclude... but one would expect good sales growth.

researched...
Sales for BARACLUDE were $36M, this recently launched product continued to gain market share.